表紙
市場調查報告書

基因編輯市場分析:各技術(CRISPR,TALEN,ZFN),各投藥法(Ex-vivo,In-vivo),各用途(動物/植物細胞編輯),各類服務(公司內部,外包),各最終用途,市場區隔預測

Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 478630
出版日期 內容資訊 英文 185 Pages
商品交期: 2-3個工作天內
價格
Back to Top
基因編輯市場分析:各技術(CRISPR,TALEN,ZFN),各投藥法(Ex-vivo,In-vivo),各用途(動物/植物細胞編輯),各類服務(公司內部,外包),各最終用途,市場區隔預測 Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014 - 2025
出版日期: 2017年02月10日內容資訊: 英文 185 Pages
簡介

本報告提供全球基因編輯市場相關調查,彙整市場趨勢,各技術,各投藥法,各用途,各類服務,各最終用途,各地區趨勢,打入市場的主要企業簡介等資料。

第1章 調查方法

第2章 摘要整理

第3章 市場變數,趨勢,範圍

  • 市場區隔和範圍
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 滲透與成長預測製圖
  • SWOT分析
  • 產業分析:波特五力分析
  • 開發平台分析
  • 智慧財產權
  • 法律規章的課題

第4章 各技術預測與趨勢分析

  • 各技術趨勢分析
  • 分子剪刀與基因編輯技術比較
  • TALEN/Mega TAL
  • ZFN
  • 其他

第5章 各投藥法預測與趨勢分析

  • 各投藥法趨勢分析
    • 投藥法比較
  • Ex-vivo
  • In-vivo

第6章 各用途趨勢分析

  • 細胞株工程
  • 動物遺傳因子工程學
  • 植物遺傳因子工程學
  • 其他

第7章 各最終用途預測與趨勢分析

  • 各最終用途趨勢分析
  • 生物科技/製藥公司
  • 學術機構,政府研究機關
  • CRO

第8章 各類服務預測與趨勢分析

  • 各類服務趨勢分析
  • 公司內部
  • 外包

第9章 各地區預測與趨勢分析

  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 競爭環境

  • 策略架構
  • 市場進入類別
  • 企業簡介
目錄
Product Code: GVR-1-68038-399-7

The global genome editing market is anticipated to reach USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for cure for specific diseases, can be attributed to induce growth in the coming years.

Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain the larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines.

Further Key Findings from the Report Suggest:

  • There has been great excitement surrounding the highly adaptable CRISPR technology.
  • The increased ease of retargeting and the ability to multiplex goes a long way toward explaining the speed with which CRISPR-centric companies have sprung up.
  • Ex-vivo mode of delivery accounted for the largest share of the revenue.
  • Therapy through ex-vivo mode of delivery allow the control over the specific dosage of therapeutic molecules delivered to cells.
  • Cell line engineering dominated with respect to revenue generation owing to the high utilization of technology in stem cell engineering.
  • There is comparatively, higher adoption of the technology in the biotechnology and pharmaceutical organizations for the purpose of therapeutic development.
  • Availability of other services such as gRNA library production and screening service along with editing is anticipated to propel growth in the outsourcing services.
  • Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising penetration of technology in comparatively immature market.
  • Key players contributing in this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou Biosciences, Inc.
  • These participants are capitalizing on unique advantages offered by the nuclease technology, they are working on.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

Chapter 3 Genome Editing Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Success in pre-clinical models drives demands for genome editing therapeutics
      • 3.1.1.2 Rising competition amongst market participants for business development
      • 3.1.1.3 Easy editing solutions for development of therapeutics for broad range of diseases
      • 3.1.1.4 Increasing demand for synthetic genes and genetically modified organisms
      • 3.1.1.5 Technological advancements in gene editing technologies
      • 3.1.1.6 Rising adoption in agricultural biotechnology
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Challenges with respect to clinical translation
      • 3.1.2.2 Regulatory, scientific, and ethical challenges pertaining to the use of gene modified products
      • 3.1.2.3 Off-target effects of CRISPR technology
  • 3.2 Penetration & Growth Prospect Mapping for Technology, 2015
  • 3.3 Molecular scissors / genome editing -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's
  • 3.5 Molecular Scissors / Genome Editing Technologies: Pipeline Analysis
    • 3.5.1 Sangamo
    • 3.5.2 Cellectis
    • 3.5.3 Calyxt
    • 3.5.4 bluebird bio
    • 3.5.5 Editas Medicine
    • 3.5.6 Intellia Therapeutics, Inc.
    • 3.5.7 CRISPR THERAPEUTICS
    • 3.5.8 Precision Biosciences
    • 3.5.9 Precision Biosciences (Non medical domain)
    • 3.5.10 Caribou Biosciences
    • 3.5.11 Cibus
    • 3.5.12 Recombinetics, Inc
  • 3.6 Intellectual Property
  • 3.7 Regulatory Issues
    • 3.7.1 Orphan diseases
    • 3.7.2 Germline editing
    • 3.7.3 Safety issues

Chapter 4 Genome Editing Market: Technology Estimates & Trend Analysis

  • 4.1 Molecular Scissors/ Genome Editing Market: Technology Movement Analysis
  • 4.2 Molecular Scissors / Genome Editing Technology Comparison
  • 4.3 (CRISPR)/Cas9
    • 4.3.1 Global (CRISPR)/Cas9 market, 2014 - 2025 (USD Million)
  • 4.4 TALENs/MegaTALs
    • 4.4.1 Global TALENs/MegaTALs market, 2014 - 2025 (USD Million)
  • 4.5 ZFN
    • 4.5.1 Global ZFN market, 2014 - 2025 (USD Million)
  • 4.6 Other Technologies
    • 4.6.1 Global other technologies market, 2014 - 2025 (USD Million)

Chapter 5 Genome Editing Market: Delivery Method Estimates & Trend Analysis

  • 5.1 Molecular Scissors/ Genome Editing Market: Delivery Method Movement Analysis
    • 5.1.1 Comparison of Delivery Methods
      • 5.1.1.1 Viral delivery
      • 5.1.1.1.1 AAV (Adeno Associated Virus).
      • 5.1.1.1.2 IDLV (Integrase Deficient Lentivirus).
      • 5.1.1.2 Non-viral delivery
      • 5.1.1.2.1 Lipid Mediated
      • 5.1.1.2.2 Electroporation
  • 5.2 Ex-vivo
    • 5.2.1 Global ex-vivo delivery market, 2014 - 2025 (USD Million)
  • 5.3 In-vivo
    • 5.3.1 Global in-vivo delivery market, 2014 - 2025 (USD Million)

Chapter 6 Genome Editing Market: Application Estimates & Trend Analysis

  • 6.1 Molecular Scissors / Genome Editing Market: Application Movement Analysis
  • 6.2 Cell Line Engineering
    • 6.2.1 Global cell line engineering market, 2014 - 2025 (USD Million)
  • 6.3 Animal Genetic Engineering
    • 6.3.1 Global animal genetic engineering market, 2014 - 2025 (USD Million)
  • 6.4 Plant Genetic Engineering
    • 6.4.1 Global plant genetic engineering market, 2014 - 2025 (USD Million)
  • 6.5 Others
    • 6.5.1 Global other applications market, 2014 - 2025 (USD Million)

Chapter 7 Genome Editing Market: End-use Estimates & Trend Analysis

  • 7.1 Molecular Scissors / Genome Editing Market: End-use Movement Analysis
  • 7.2 Biotechnology & Pharmaceutical Companies
    • 7.2.1 Global biotechnology & pharmaceutical companies market, 2014 - 2025 (USD Million)
  • 7.3 Academic & Government Research Institutes
    • 7.3.1 Global academic & government research institutes market, 2014 - 2025 (USD Million)
  • 7.4 Contract Research Organizations (CROs)
    • 7.4.1 Global CROs market, 2014 - 2025 (USD Million)

Chapter 8 Genome Editing Market: Service Estimates & Trend Analysis

  • 8.1 Molecular scissors / genome editing Market: Service Movement Analysis
  • 8.2 In-house
    • 8.2.1 Global in-house gene editing market, 2014 - 2025 (USD Million)
  • 8.3 Contract
    • 8.3.1 Global contract gene editing services market, 2014 - 2025 (USD Million)

Chapter 9 Genome Editing Market: Regional Estimates & Trend Analysis, by Technology, Delivery Method, Application, End-use, & Service

  • 9.1 Molecular Scissors / Genome Editing Market Share By Region, 2015 & 2025
  • 9.2 North America
    • 9.2.1 North America molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S molecular scissors / genome editing culture market, 2014 - 2025 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.3.3 UK
      • 9.3.3.1 UK molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • 9.6 Middle East & Africa
    • 9.6.1 Middle East & Africa molecular scissors / genome editing market, 2014 - 2025 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa molecular scissors / genome editing market, 2014 - 2025 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Strategy Framework
    • 10.1.1 Genome editing companies are developing products in a range of markets
    • 10.1.2 Genome Editing Companies are targeting a variety of markets of various sizes
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 Merck KGaA
      • 10.3.1.1 Company overview
      • 10.3.1.1.1 Sigma-Aldrich Co. LLC
      • 10.3.1.2 Financial performance
      • 10.3.1.2.1 Financial performance
      • 10.3.1.3 Product benchmarking
      • 10.3.1.4 Strategic initiatives
    • 10.3.2 Cibus
      • 10.3.2.1 Company overview
      • 10.3.2.1.1 Nucelis
      • 10.3.2.2 Financial performance
      • 10.3.2.2.1 Financial performance
      • 10.3.2.3 Product benchmarking
      • 10.3.2.4 Strategic initiatives
    • 10.3.3 Recombinetics, Inc
      • 10.3.3.1 Company overview
      • 10.3.3.2 Financial performance
      • 10.3.3.3 Product benchmarking
      • 10.3.3.4 Strategic initiatives
    • 10.3.4 Sangamo
      • 10.3.4.1 Company overview
      • 10.3.4.2 Financial performance
      • 10.3.4.3 Product benchmarking
      • 10.3.4.4 Strategic initiatives
    • 10.3.5 Editas Medicine
      • 10.3.5.1 Company overview
      • 10.3.5.2 Financial performance
      • 10.3.5.3 Product benchmarking
      • 10.3.5.4 Strategic initiatives
    • 10.3.6 Precision Biosciences
      • 10.3.6.1 Company overview
      • 10.3.6.2 Financial performance
      • 10.3.6.3 Product benchmarking
      • 10.3.6.4 Strategic initiatives
    • 10.3.7 CRISPR THERAPEUTICS
      • 10.3.7.1 Company overview
      • 10.3.7.2 Financial performance
      • 10.3.7.3 Product benchmarking
      • 10.3.7.4 Strategic initiatives
    • 10.3.8 Intellia Therapeutics, Inc.
      • 10.3.8.1 Company overview
      • 10.3.8.2 Financial performance
      • 10.3.8.3 Product benchmarking
      • 10.3.8.4 Strategic initiatives
    • 10.3.9 Caribou Biosciences, Inc
      • 10.3.9.1 Company overview
      • 10.3.9.2 Financial performance
      • 10.3.9.3 Product benchmarking
      • 10.3.9.4 Strategic initiatives
    • 10.3.10 Cellectis
      • 10.3.10.1 Company overview
      • 10.3.10.1.1 Calyxt
      • 10.3.10.2 Financial performance
      • 10.3.10.2.1 Financial performance (Calyxt)
      • 10.3.10.3 Product benchmarking
      • 10.3.10.4 Strategic initiatives
    • 10.3.11 AstraZeneca
      • 10.3.11.1 Company overview
      • 10.3.11.2 Financial performance
      • 10.3.11.3 Product benchmarking
      • 10.3.11.4 Strategic initiatives
    • 10.3.12 Takara Bio USA
      • 10.3.12.1 Company overview
      • 10.3.12.2 Financial performance
      • 10.3.12.3 Product benchmarking
      • 10.3.12.4 Strategic initiatives
    • 10.3.13 Horizon Discovery Group plc
      • 10.3.13.1 Company overview
      • 10.3.13.2 Financial performance
      • 10.3.13.3 Product benchmarking
      • 10.3.13.4 Strategic initiatives
    • 10.3.14 Integrated DNA Technologies, Inc.
      • 10.3.14.1 Company overview
      • 10.3.14.2 Financial performance
      • 10.3.14.3 Product benchmarking
    • 10.3.15 Egenesis Inc.
      • 10.3.15.1 Company overview
      • 10.3.15.2 Financial performance
      • 10.3.15.3 Product benchmarking
    • 10.3.16 GenScript
      • 10.3.16.1 Company overview
      • 10.3.16.2 Financial performance
      • 10.3.16.3 Product benchmarking
      • 10.3.16.4 Strategic initiatives
    • 10.3.17 New England Biolabs
      • 10.3.17.1 Company overview
      • 10.3.17.2 Financial performance
      • 10.3.17.3 Product benchmarking
      • 10.3.17.4 Strategic initiatives
    • 10.3.18 OriGene Technologies, Inc.
      • 10.3.18.1 Company overview
      • 10.3.18.2 Financial performance
      • 10.3.18.3 Product benchmarking
      • 10.3.18.4 Strategic initiatives
    • 10.3.19 bluebird bio, Inc.
      • 10.3.19.1 Company overview
      • 10.3.19.1.1 Precision Genome Engineering, Inc. (Pregenen)
      • 10.3.19.2 Financial performance
      • 10.3.19.2.1 Financial performance
      • 10.3.19.3 Product benchmarking
      • 10.3.19.4 Strategic initiatives
    • 10.3.20 Lonza
      • 10.3.20.1 Company overview
      • 10.3.20.2 Financial performance
      • 10.3.20.3 Product benchmarking
      • 10.3.20.4 Strategic initiatives
    • 10.3.21 Thermo Fisher Scientific, Inc.
      • 10.3.21.1 Company overview
      • 10.3.21.2 Financial performance
      • 10.3.21.3 Product benchmarking
      • 10.3.21.4 Strategic initiatives

List of Tables

  • TABLE 1: Molecular scissors / genome editing technology comparison
  • TABLE 2: North America molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 3: North America molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 4: North America molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 5: North America molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 6: North America molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 7: U.S. molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 8: U.S. molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 9: U.S. molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 10: U.S. molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 11: U.S. molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 12: Canada molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 13: Canada molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 14: Canada molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 15: Canada molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 16: Canada molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 17: Europe molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 18: Europe molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 19: Europe molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 20: Europe molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 21: Europe molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 22: Germany molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 23: Germany molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 24: Germany molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 25: Germany molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 26: Germany molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 27: UK molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 28: UK molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 29: UK molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 30: UK molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 31: UK molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 32: Asia Pacific molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 33: Asia Pacific molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 34: Asia Pacific molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 35: Asia Pacific molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 36: Asia Pacific molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 37: Japan molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 38: Japan molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 39: Japan molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 40: Japan molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 41: Japan molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 42: China molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 43: China molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 44: China molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 45: China molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 46: China molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 47: Latin America molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 48: Latin America molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 49: Latin America molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 50: Latin America molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 51: Latin America molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 52: Brazil molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 53: Brazil molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 54: Brazil molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 55: Brazil molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 56: Brazil molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 57: MEA molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 58: MEA molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 59: MEA molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 60: MEA molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 61: MEA molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)
  • TABLE 62: South Africa molecular scissors / genome editing market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
  • TABLE 63: South Africa molecular scissors / genome editing market estimates & forecasts, by delivery method, 2014 - 2025 (USD Million)
  • TABLE 64: South Africa molecular scissors / genome editing market estimates & forecasts, by application, 2014 - 2025 (USD Million)
  • TABLE 65: South Africa molecular scissors / genome editing market estimates & forecasts, by end-use, 2014 - 2025 (USD Million)
  • TABLE 66: South Africa molecular scissors / genome editing market estimates & forecasts, by service, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information Procurement
  • FIG. 3: Primary research pattern
  • FIG. 4: Market research approaches
  • FIG. 5: Value chain based sizing & forecasting
  • FIG. 6: QFD modelling for market share assessment
  • FIG. 7: Market summary
  • FIG. 8: Market trends & outlook
  • FIG. 9: Market segmentation & scope
  • FIG. 10: Market driver relevance analysis (Current & future impact)
  • FIG. 11: Applications of genome editing in therapeutic models
  • FIG. 12: Market restraint relevance analysis (Current & future impact)
  • FIG. 13: Penetration & growth prospect mapping for Technology, 2015
  • FIG. 14: SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 15: Porter's Five Forces Analysis
  • FIG. 16: Molecular scissors / genome editing market: Technology outlook key takeaways
  • FIG. 17: Molecular scissors / genome editing market: Technology movement analysis
  • FIG. 18: Global (CRISPR)/Cas9 market, 2014 - 2025 (USD Million)
  • FIG. 19: Global TALENs/MegaTALs market, 2014 - 2025 (USD Million)
  • FIG. 20: Global ZFN market, 2014 - 2025 (USD Million)
  • FIG. 21: Global other technologies market, 2014 - 2025 (USD Million)
  • FIG. 22: Molecular scissors / genome editing market: Delivery method outlook key takeaways
  • FIG. 23: Molecular scissors / genome editing market: Delivery method movement analysis
  • FIG. 24: Global ex-vivo delivery market, 2014 - 2025 (USD Million)
  • FIG. 25: Global in-vivo delivery market, 2014 - 2025 (USD Million)
  • FIG. 26: Molecular scissors / genome editing market: Application outlook key takeaways
  • FIG. 27: Global molecular scissors / genome editing market: Application movement analysis
  • FIG. 28: Global Cell Line Engineering market, 2014 - 2025 (USD Million)
  • FIG. 29: Global animal genetic engineering market, 2014 - 2025 (USD Million)
  • FIG. 30: Global plant genetic engineering market, 2014 - 2025 (USD Million)
  • FIG. 31: Global other applications market, 2014 - 2025 (USD Million)
  • FIG. 32: Molecular scissors / genome editing market: End-use outlook key takeaways
  • FIG. 33: Global molecular scissors / genome editing market: End-use movement analysis
  • FIG. 34: Global biotechnology & pharmaceutical companies market, 2014 - 2025 (USD Million)
  • FIG. 35: Global academic & government research institutes market, 2014 - 2025 (USD Million)
  • FIG. 36: Global CROs market, 2014 - 2025 (USD Million)
  • FIG. 37: Molecular scissors / genome editing market: Service outlook key takeaways
  • FIG. 38: Global molecular scissors / genome editing market: Service movement analysis
  • FIG. 39: Global in-house gene editing market, 2014 - 2025 (USD Million)
  • FIG. 40: Global contract gene editing services market, 2014 - 2025 (USD Million)
  • FIG. 41: Regional market place: Key takeaway
  • FIG. 42: Molecular scissors / genome editing regional outlook, 2015 & 2025
  • FIG. 43: North America molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 44: U.S molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 45: Canada molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 46: Europe molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 47: Germany molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 48: UK molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 49: Asia Pacific molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 50: Japan molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 51: China molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 52: Latin America molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 53: Brazil molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 54: Middle East & Africa molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 55: South Africa molecular scissors / genome editing market, 2014 - 2025 (USD Million)
  • FIG. 56: Strategy framework
  • FIG. 57: Participant categorization
Back to Top